Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Ossia M Eichhoff"'
Autor:
Ramile Dilshat, Valerie Fock, Colin Kenny, Ilse Gerritsen, Romain Maurice Jacques Lasseur, Jana Travnickova, Ossia M Eichhoff, Philipp Cerny, Katrin Möller, Sara Sigurbjörnsdóttir, Kritika Kirty, Berglind Ósk Einarsdottir, Phil F Cheng, Mitchell Levesque, Robert A Cornell, E Elizabeth Patton, Lionel Larue, Marie de Tayrac, Erna Magnúsdóttir, Margrét Helga Ögmundsdóttir, Eirikur Steingrimsson
Publikováno v:
eLife, Vol 10 (2021)
The microphthalmia-associated transcription factor (MITF) is a critical regulator of melanocyte development and differentiation. It also plays an important role in melanoma where it has been described as a molecular rheostat that, depending on activi
Externí odkaz:
https://doaj.org/article/8ad19d9f458540fd98b942289d5c7ef2
Autor:
Nina Zila, Andrea Bileck, Besnik Muqaku, Lukas Janker, Ossia M. Eichhoff, Phil F. Cheng, Reinhard Dummer, Mitchell P. Levesque, Christopher Gerner, Verena Paulitschke
Publikováno v:
Clinical Proteomics, Vol 15, Iss 1, Pp 1-22 (2018)
Abstract Background MAP kinase inhibitor (MAPKi) therapy for BRAF mutated melanoma is characterized by high response rates but development of drug resistance within a median progression-free survival (PFS) of 9–12 months. Understanding mechanisms o
Externí odkaz:
https://doaj.org/article/3c05226649704612ad3c346883feffbc
Autor:
Mitchell P. Levesque, Reinhard Dummer, Héctor Peinado, Carlo Pincelli, Alessandra Marconi, Francesca Truzzi, Ossia M. Eichhoff, Patrick Turko, Phil F. Cheng, Corinne Isabelle Stoffel, Laura Nogués, Susana Garcia-Silva, Alberto Hernández-Barranco, Nicola Facchinello, Natascia Tiso, Marika Quadri, Andreas Dzung, Annalisa Saltari
Evaluation of caspae 3 staining after treatment with Aβ(25-35) in mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4877b1933a73a6f201ed23a07472209
https://doi.org/10.1158/0008-5472.22561927.v1
https://doi.org/10.1158/0008-5472.22561927.v1
Autor:
Mitchell P. Levesque, Reinhard Dummer, Héctor Peinado, Carlo Pincelli, Alessandra Marconi, Francesca Truzzi, Ossia M. Eichhoff, Patrick Turko, Phil F. Cheng, Corinne Isabelle Stoffel, Laura Nogués, Susana Garcia-Silva, Alberto Hernández-Barranco, Nicola Facchinello, Natascia Tiso, Marika Quadri, Andreas Dzung, Annalisa Saltari
CD271 (NGFR) is a neurotrophin receptor that belongs to the tumor necrosis receptor (TNFR) family. Upon ligand binding, CD271 can mediate either survival or cell death. Although the role of CD271 as a marker of tumor-initiating cells is still a matte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::514e0bae60e8bcc98838789f00ce9b53
https://doi.org/10.1158/0008-5472.c.6565189
https://doi.org/10.1158/0008-5472.c.6565189
Autor:
Mitchell P. Levesque, Reinhard Dummer, Berend Snijder, Martin Distel, Thorsten Hornemann, Stuart L. Schreiber, Michael Krauthammer, Andreas Dzung, Annalisa Saltari, Andrea Aloia, Judith Wenzina, Vasanthi S. Viswanathan, Alaa Othman, Julien Mena, Rebekka Wegmann, Pål Johansen, Susana Pascoal, Aizhan Tastanova, Zsolt Balazs, Anja Irmisch, Nicola Zamboni, Andrea Bileck, Alexander Leitner, Phil F. Cheng, Verena Paulitschke, Nina Zila, Gergely Karsai, Patrick Turko, Luzia Briker, Jan Käsler, Corinne I. Stoffel, Ossia M. Eichhoff
Tumor Profiler Consortium author list
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1793b5a380d7fd2ae0dc078b2363f59f
https://doi.org/10.1158/0008-5472.22549700.v1
https://doi.org/10.1158/0008-5472.22549700.v1
Autor:
Mitchell P. Levesque, Reinhard Dummer, Berend Snijder, Martin Distel, Thorsten Hornemann, Stuart L. Schreiber, Michael Krauthammer, Andreas Dzung, Annalisa Saltari, Andrea Aloia, Judith Wenzina, Vasanthi S. Viswanathan, Alaa Othman, Julien Mena, Rebekka Wegmann, Pål Johansen, Susana Pascoal, Aizhan Tastanova, Zsolt Balazs, Anja Irmisch, Nicola Zamboni, Andrea Bileck, Alexander Leitner, Phil F. Cheng, Verena Paulitschke, Nina Zila, Gergely Karsai, Patrick Turko, Luzia Briker, Jan Käsler, Corinne I. Stoffel, Ossia M. Eichhoff
Table ST5: Table of the 15 most informative proteins upregulated in MEK inhibitor-resistant cell culture (ranked by log2 fold-change).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bab8c00b4082577dcc6041ba84a6950b
https://doi.org/10.1158/0008-5472.22549685
https://doi.org/10.1158/0008-5472.22549685
Autor:
Mitchell P. Levesque, Reinhard Dummer, Berend Snijder, Martin Distel, Thorsten Hornemann, Stuart L. Schreiber, Michael Krauthammer, Andreas Dzung, Annalisa Saltari, Andrea Aloia, Judith Wenzina, Vasanthi S. Viswanathan, Alaa Othman, Julien Mena, Rebekka Wegmann, Pål Johansen, Susana Pascoal, Aizhan Tastanova, Zsolt Balazs, Anja Irmisch, Nicola Zamboni, Andrea Bileck, Alexander Leitner, Phil F. Cheng, Verena Paulitschke, Nina Zila, Gergely Karsai, Patrick Turko, Luzia Briker, Jan Käsler, Corinne I. Stoffel, Ossia M. Eichhoff
S13: Immunohistochemical analysis of CyTof biomarker panel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4117e07f527972268e9d33eaec557930
https://doi.org/10.1158/0008-5472.22549733.v1
https://doi.org/10.1158/0008-5472.22549733.v1
Autor:
Mitchell P. Levesque, Reinhard Dummer, Berend Snijder, Martin Distel, Thorsten Hornemann, Stuart L. Schreiber, Michael Krauthammer, Andreas Dzung, Annalisa Saltari, Andrea Aloia, Judith Wenzina, Vasanthi S. Viswanathan, Alaa Othman, Julien Mena, Rebekka Wegmann, Pål Johansen, Susana Pascoal, Aizhan Tastanova, Zsolt Balazs, Anja Irmisch, Nicola Zamboni, Andrea Bileck, Alexander Leitner, Phil F. Cheng, Verena Paulitschke, Nina Zila, Gergely Karsai, Patrick Turko, Luzia Briker, Jan Käsler, Corinne I. Stoffel, Ossia M. Eichhoff
S16: scRNA-sequencing analysis of xenograft tumors M130227
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::128793efeb32aca7a82defd37edef78f
https://doi.org/10.1158/0008-5472.22549703
https://doi.org/10.1158/0008-5472.22549703
Autor:
Mitchell P. Levesque, Reinhard Dummer, Berend Snijder, Martin Distel, Thorsten Hornemann, Stuart L. Schreiber, Michael Krauthammer, Andreas Dzung, Annalisa Saltari, Andrea Aloia, Judith Wenzina, Vasanthi S. Viswanathan, Alaa Othman, Julien Mena, Rebekka Wegmann, Pål Johansen, Susana Pascoal, Aizhan Tastanova, Zsolt Balazs, Anja Irmisch, Nicola Zamboni, Andrea Bileck, Alexander Leitner, Phil F. Cheng, Verena Paulitschke, Nina Zila, Gergely Karsai, Patrick Turko, Luzia Briker, Jan Käsler, Corinne I. Stoffel, Ossia M. Eichhoff
Clinical management of melanomas with NRAS mutations is challenging. Targeting MAPK signaling is only beneficial to a small subset of patients due to resistance that arises through genetic, transcriptional, and metabolic adaptation. Identification of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::273c0a1e2eba8759723b206ea2872e31
https://doi.org/10.1158/0008-5472.c.6514435.v1
https://doi.org/10.1158/0008-5472.c.6514435.v1
Autor:
Reinhard Dummer, Silvio Hemmi, Leo Schaerer, Nikita Kobert, Udo Döbbeling, Natalie C. Schlegel, Ossia M. Eichhoff, Keith S. Hoek
Metastatic melanoma represents a complex and heterogeneous disease for which there are no therapies to improve patient survival. Recent expression profiling of melanoma cell lines identified two transcription signatures, respectively, corresponding w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d076cb53cce59e605b56f7e80ebb8a10
https://doi.org/10.1158/0008-5472.c.6497642
https://doi.org/10.1158/0008-5472.c.6497642